aTyr Pharma, Inc.ATYRNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.9%
5Y CAGR+13.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+11.9%/yr
vs +1.3%/yr prior
5Y CAGR
+13.6%/yr
Consistent
Acceleration
+10.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $17.20M | +24.9% |
| 2024 | $13.78M | +6.1% |
| 2023 | $12.98M | +5.6% |
| 2022 | $12.29M | +14.3% |
| 2021 | $10.75M | +18.5% |
| 2020 | $9.07M | -3.0% |
| 2019 | $9.35M | -20.0% |
| 2018 | $11.69M | -28.6% |
| 2017 | $16.36M | +15.3% |
| 2016 | $14.19M | - |